Matisse Pharmaceuticals B.V.
Entity

  • Matisse Pharmaceuticals B.V.

    Created in 2014
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    329

  • Activities

    deeptech biotech

  • Entity types

    Startup

  • Location

    Burgemeester Lemmensstraat 352, 6163 JT Geleen, Netherlands

    Geleen

    Netherlands

  • Employees

    Scale: 11-50

    Estimated: 9

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    2 months, 3 weeks ago
Description
  • Value proposition

    Developing solutions to treat life-threatening inflammation.

    Matisse Pharmaceuticals BV was founded in 2014 in Geleen, the Netherlands. Matisse targets life-threatening inflammation by neutralizing cytotoxic components of the inflammatory system. Its main development program is the development of a medicine to fight sepsis and septic shock, which is currently in clinical phase.

  • Matisse pharmaceuticals | Saving millions of lives by effectively neutralizing xcytotoxic histones.

    Saving millions of lives by effectively neutralizing xcytotoxic histones.

    • https://www.matissepharmaceuticals.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics